CClinicalTrials.gg
RecruitingNCT07378631Updated Sep 2, 2026

Association Between Clinical Classification and Prognosis in Chronic Radiation Enteropathy

An observational study in Radiotherapy, Radiation Proctitis and Radiation Enteritis, sponsored by Sixth Affiliated Hospital, Sun Yat-sen University. Recruiting at 1 site in China. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-09-02.

Sponsored by Sixth Affiliated Hospital, Sun Yat-sen University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
150
Ages
18 Years to 80 Years
Sex
All
01

Study summary

This is a prospective, observational study aimed at exploring the associations between the clinical classification of chronic radiation enteropathy and prognosis. The study is planed to commence in November 2025 and prospectively observe 150 patients. During the study period, researchers will not intervene in clinical treatment decisions but will only collect patient clinical information, intestinal endoscopy/imaging/pathological data, test results, and follow-up data. The study results will fill the evidence gap in this field, advance the diagnosis and treatment of chronic radiation enteropathy, and provide scientific support for improving the prognosis of similar patients.

02

Conditions studied

  • Radiotherapy
  • Radiation Proctitis
  • Radiation Enteritis

Keywords

  • radiotherapy
  • radiation proctitis
  • radiation enteritis
03

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population will consist of prospectively recruited adult patients clinically diagnosed with chronic radiation enteropathy at the Sixth Affiliated Hospital of Sun Yat-sen University. The inclusion criteria are: age between 18 and 80 years, and a clinical confirmation of chronic radiation enteropathy. Patients who are currently undergoing cancer therapy or who have experienced tumor recurrence or metastasis are excluded. This study will be conducted in accordance with the Declaration of Helsinki and has been approved by the hospital's Ethics Committee. Written informed consent will be obtained from all participants prior to their enrollment.

Inclusion criteria

  1. 18-80 years;
  2. Diagnosed with chronic radiation enteropathy.

Exclusion criteria

Exclusion Criteria:

  1. Ongoing cancer therapy;
  2. Tumor recurrence or metastasis.
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
150 participants (estimated)
Patient registry
No

Groups and cohorts

  • Chronic radiation enteropathy

    Patients diagnosed with chronic radiation enteropathy

05

What researchers measure

Primary outcomes

  1. Association between Clinical Classification and Clinical Outcomes

    To investigate the association between clinical classification and outcomes, the primary outcome was assessed as complete remission of their primary symptom, while the measure was identified as the remission rate.

    Time frame: 6 months

Secondary outcomes

  1. Predictive Accuracy of Endoscopic Characteristics for Clinical Classification

    Using prospectively collected endoscopic data, the investigators will assess the association between specific endoscopic features and the data-driven clinical classification. The predictive accuracy will be quantitatively measured using metrics including sensitivity and specificity. The results aim to determine whether endoscopic findings can serve as reliable indicators for subtype identification.

    Time frame: 6 months

  2. Predictive Accuracy of Imaging Evaluation for Clinical Classification

    Using prospectively collected endoscopic data, the investigators will assess the association between features of MRI/CT and the data-driven clinical classification. The predictive accuracy will be quantitatively measured using metrics including sensitivity and specificity. The results aim to determine whether endoscopic findings can serve as reliable indicators for subtype identification.

    Time frame: 6 months

06

Study locations

1 of 1 sites recruiting
  • The Sixth Affiliated Hospital, Sun Yat-sen University
    Guangzhou, Guangdong, China
    Recruiting
07

Registry details

Key details

Study ID
NCT07378631
Lead sponsor
Sixth Affiliated Hospital, Sun Yat-sen University
Responsible party
Sponsor
First posted
Jan 30, 2026
Start date
Dec 4, 2025
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Sep 2, 2026

Study contacts

Qiyuan Qin, M.D.
Contact
qinqy3@mail.sysu.edu.cn
86-13580359171

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion